Back to overview

Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability.

Type of publication Peer-reviewed
Publikationsform Original article (peer-reviewed)
Publication date 2013
Author Asadollahi Reza, Oneda Beatrice, Sheth Frenny, Azzarello-Burri Silvia, Baldinger Rosa, Joset Pascal, Latal Beatrice, Knirsch Walter, Desai Soaham, Baumer Alessandra, Houge Gunnar, Andrieux Joris, Rauch Anita,
Project Identification of novel autosomal genes causing mental retardation
Show all

Original article (peer-reviewed)

Journal European journal of human genetics : EJHG
Volume (Issue) 21(10)
Page(s) 1100 - 4
Title of proceedings European journal of human genetics : EJHG
DOI 10.1038/ejhg.2013.17

Open Access

Type of Open Access Publisher (Gold Open Access)


A chromosomal balanced translocation disrupting the MED13L (Mediator complex subunit13-like) gene, encoding a subunit of the Mediator complex, was previously associated with transposition of the great arteries (TGA) and intellectual disability (ID), and led to the identification of missense mutations in three patients with isolated TGA. Recently, a homozygous missense mutation in MED13L was found in two siblings with non-syndromic ID from a consanguineous family. Here, we describe for the first time, three patients with copy number changes affecting MED13L and delineate a recognizable MED13L haploinsufficiency syndrome. Using high resolution molecular karyotyping, we identified two intragenic de novo frameshift deletions, likely resulting in haploinsufficiency, in two patients with a similar phenotype of hypotonia, moderate ID, conotruncal heart defect and facial anomalies. In both, Sanger sequencing of MED13L did not reveal any pathogenic mutation and exome sequencing in one patient showed no evidence for a non-allelic second hit. A further patient with hypotonia, learning difficulties and perimembranous VSD showed a 1 Mb de novo triplication in 12q24.2, including MED13L and MAP1LC3B2. Our findings show that MED13L haploinsufficiency in contrast to the previously observed missense mutations cause a distinct syndromic phenotype. Additionally, a MED13L copy number gain results in a milder phenotype. The clinical features suggesting a neurocristopathy may be explained by animal model studies indicating involvement of the Mediator complex subunit 13 in neural crest induction.